Evaluation of Immune Checkpoint Inhibitor-Associated High- Grade Colitis/Diarrhea Frequency and Management.
- Published in:
- Journal of Enterocolitis, 2023, v. 2, n. 1, p. 6, doi. 10.14744/Jenterocolitis.2023.222035
- By:
- Publication type:
- Article
Works matching IS 28222741 AND DT 2023 AND VI 2 AND IP 1
Results: 5
1
2
Mucocutaneous Manifestations in Inflammatory Bowel Disease.
- Published in:
- Journal of Enterocolitis, 2023, v. 2, n. 1, p. 1, doi. 10.14744/Jenterocolitis.2023.230139
- By:
- Publication type:
- Article
3
Pseudomembranous Colitis Incidentally Detected on FDG PET/CT.
- Published in:
- Journal of Enterocolitis, 2023, v. 2, n. 1, p. 17, doi. 10.14744/Jenterocolitis.2023.230241
- By:
- Publication type:
- Article
4
Crohn’s Disease Present with Hypopharynx Ulcer and Retropharyngeal Microabscess.
- Published in:
- Journal of Enterocolitis, 2023, v. 2, n. 1, p. 15, doi. 10.14744/Jenterocolitis.2023.230547
- By:
- Publication type:
- Article
5
Clinical, Laboratory, and Endoscopic Efficacy of Adalimumab and Infliximab in Inflammatory Bowel Disease.
- Published in:
- Journal of Enterocolitis, 2023, v. 2, n. 1, p. 10, doi. 10.14744/jenterocolitis.2023.230445
- By:
- Publication type:
- Article